Company registration number: 09132651
Annual report and unaudited financial statements
for the year ended 30 December 2025
for
Protex Healthcare (Uk) Ltd
Pages for filing with the Registrar
Company registration number: 09132651
Protex Healthcare (Uk) Ltd
Balance sheet
as at 30 December 2025
2025 2024
Note £ £ £ £
Fixed assets
Intangible assets 4 14,343 22,980
Tangible assets 5 - 135
Investments 6 110,992 110,992
125,335 134,107
Current assets
Debtors 630,004 520,830
Cash at bank and in hand 356 84
630,360 520,914
Creditors: amounts falling due within one year
(1,391,061) (212,550)
Net current (liabilities)/assets (760,701) 308,364
Total assets less current liabilities (635,366) 442,471
Creditors: Amounts falling due after more than one year
(111,049) (1,204,387)
NET LIABILITIES (746,415) (761,916)
Capital and reserves
Called up share capital 150 150
Share premium account 581,327 581,327
Profit and loss account (1,327,892) (1,343,393)
TOTAL EQUITY (746,415) (761,916)
The company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies for the year ended 30 December 2025.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities to comply with the Companies Act 2006 in respect to accounting records and the preparation of financial statements.
1
Company registration number: 09132651
Protex Healthcare (Uk) Ltd
Balance sheet - continued
as at 30 December 2025
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
In accordance with Section 444 of the Companies Act 2006, the Profit and loss account has not been delivered to the Registrar.
These financial statements were approved by the Board of directors and authorised for issue on 16 September 2026 and signed on its behalf by:
Mr D Viaene, Director
16 September 2026
2
Protex Healthcare (Uk) Ltd
Notes to the financial statements
for the year ended 30 December 2025
1 Company information
Protex Healthcare (Uk) Ltd is a private company registered in England and Wales. Its registered number is 09132651. The company is limited by shares. Its registered office is Innovation Centre, Gallows Hill, Warwick, CV34 6UW.
2 Accounting policies
Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” including the provisions of Section 1A “Small Entities” and the Companies Act 2006. The financial statements have been prepared under the historic cost convention.
Going concern
In preparing these financial statements, the directors have assessed whether there are any material uncertainties related to events or conditions that cast significant doubt upon the company’s ability to continue as a going concern. In making this assessment, the directors take into account all available information about the future which is at least 12 months from the date that the financial statements are authorised for issue.
The directors consider that the company has adequate resources to continue in business for the foreseeable future and that it is appropriate to adopt the going concern basis in preparing the financial statements.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, Value Added Tax and other sales taxes.
Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.
Amortisation is provided at the following annual rates in order to write off each asset over its estimated useful life.
trademark - 20% straight line
Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Plant and machinery etc.:
Plant and machinery - 25% straight line
Computer equipment - 25% straight line
3
Protex Healthcare (Uk) Ltd
Notes to the financial statements - continued
for the year ended 30 December 2025
2 Accounting policies - continued
Taxation
Taxation for the year comprises current taxation. Tax is recognised in the Profit and loss account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.
Current taxation assets and liabilities are not discounted.
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.
3 Average number of employees
During the year the average number of employees was Nil (2024 - Nil).
4 Intangible assets
Other intangible assets

£
Cost
At 31 December 2024 45,183
At 30 December 2025 45,183
Amortisation
At 31 December 2024 22,203
Charge for year 8,637
At 30 December 2025 30,840
Net book value
At 30 December 2025 14,343
At 30 December 2024 22,980
Revalued assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairments losses.
4
Protex Healthcare (Uk) Ltd
Notes to the financial statements - continued
for the year ended 30 December 2025
5 Tangible fixed assets
Plant and machinery etc.

£
Cost
At 31 December 2024 14,309
At 30 December 2025 14,309
Depreciation
At 31 December 2024 14,174
Charge for year 135
At 30 December 2025 14,309
Net book value
At 30 December 2025 -
At 30 December 2024 135
6 Fixed asset investments
Investments other than loans
Other investments other than loans


£
Cost
At 31 December 2024 110,992
At 30 December 2025 110,992
Net book value
At 30 December 2025 110,992
At 30 December 2024 110,992
7 Related party transactions
5
Protex Healthcare (Uk) Ltd
Notes to the financial statements - continued
for the year ended 30 December 2025
7 Related party transactions - continued
During the year management charges of £86,523 (2024: £91,715) were charged to directors’ private companies for work carried out by them on the company’s behalf. At the year end in the other creditors there were balances related to directors private companies: MarketMaker of £611,288 Collshaw Consulting £248,012 Andrews Medical & Technical Consultancy Services £114,329. Protex Healthcare (UK) has 100% shares in following companies: Protex Healthcare N.V (Belgian company) and Protex Medical Product LLC (U.S company). £71,008 balance in the other debtors relates to Protex Healtcare N.V. and £59,289 balance relates to Protex Healthcare Nederland BV (Dutch company owned by Protex Healthcare N.V).







6